Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

SynMech · A synaptic mechanogenetic technology to repair brain connectivity

HORIZONStatus: SIGNED1 February 202331 January 2028EU funding €3,543,967Call HORIZON-EIC-2022-PATHFINDEROPEN-01

We aim to develop a mechanogenetic technology to regulate functional connectivity of neural circuits, and show how it can be harnessed for therapeutic purposes in high-prevalence treatment-resistant brain disorders.Mechanogenetics is an emerging field of health science that attempts to regulate neural networks by combining the advantages of optogenetics with those of magneto-mechanical stimulations; like optogenetics, it relies on targeted actuators to achieve circuit specificity, while exploiting magnetic fields to remotely stimulate the brain. Yet, despite solid theoretical foundations and encouraging experimental results, we are to date unable to repair a dysfunctional brain using mechanogenetics due to technological barriers in spatial resolution and in vivo implementation.We propose an innovative solution based on functionalized biocompatible magnetic nanoparticles and bioengineered synaptic mechanosensors that synergistically integrate at specific synaptic connections to bidirectionally regulate brain circuit connectivity in response to focused magnetic fields of different frequencies delivered via high-permeability transcranial magnetic stimulators. By hijacking the signaling pathways of synaptic mechanosensors, we aim to promote a normalization of neural circuit activity that outlasts the therapeutic intervention. We will assess the capacity of the synaptic mechanogenetic toolkit to promote and depress network activity in mouse models of stroke and epilepsy.To achieve this ambitious goal, we have gathered an interdisciplinary consortium going from material scientists and electronic experts to physiologists and clinicians. Our approach, based on magnetic fields that penetrate brain tissue unimpeded, is predicted to go beyond current therapeutic paradigms because it does not require implantation of invasive devices, and at the same time, promises to achieve subcellular resolution for repairing connectivity defects that underlie most brain disorders.

Consortium · 8 organisations

coordinator

UNIVERSITA DEGLI STUDI DI TRIESTE

IT · €1,013,522

participant

BRAIN SCIENCE TOOLS B.V.

NL · €280,750

participant

UNIVERSITA DEGLI STUDI DI VERONA

IT · €343,786

participant

DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV

DE · €458,986

participant

FORSCHUNGSZENTRUM JULICH GMBH

DE · €232,173

participant

BIOTALENTUM TUDASFEJLESZTO KFT

HU · €495,875

participant

CONSIGLIO NAZIONALE DELLE RICERCHE

IT · €280,640

participant

UNIVERSITAIR MEDISCH CENTRUM UTRECHT

NL · €438,235

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.